Trading Signals: UTHR Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Fri. Dec. 22, 2023)( United Therapeutics Corp)
| UTHR latest price $113.9000 (-1.6%) ($112.2500 - $115.1500) on Tue. Jan. 22, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.59% (three month average) | RSI | 66 | Latest Price | $113.9000(-1.6%) | Stocks Behave Similarly | Similar Stock List | Weekly Trend | UTHR advances 1.9% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support UTHR advance at 0% a week (0% probability) XLV(43%) IBB(42%) XBI(41%) VFMO(39%) VT(39%) | Factors Impacting UTHR price | UTHR will decline at least -1.295% in a week (0% probabilities). VXX(-13%) TLT(-13%) VIXM(-10%) UUP(-10%) XHB(-2%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.295% (StdDev 2.59%) | Hourly BBV | 0 () | Intraday Trend | -1.1% | | | |
|
5 Day Moving Average | $114.48(-0.51%) | 10 Day Moving Average | $114.26(-0.32%) | 20 Day Moving Average | $110.88(2.72%) | To recent high | -8.5% | To recent low | 12.3% | Market Cap | $5.052b | | | | United Therapeutics Corp. operates as a biotechnology company, which engages in the development and commercialization of products for patients with chronic and life-threatening diseases. It markets and sells commercial therapies to treat pulmonary arterial hypertension and high-risk neuroblastoma. The firm also involves in the research and development of new indications and delivery devices for its product, and for the organ transplantation-related technologies. The company was founded by Martine A. Rothblatt on June 26, 1996 and is headquartered in Silver Spring, MD. |